Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Hanwei Technology and others set up a new company in Hubei, including geographic remote sensing information service business. The enterprise search APP shows that recently, Hubei Hanwei Water Technology Co., Ltd. was established, with Zhao Shuai as the legal representative and a registered capital of 10 million yuan. Its business scope includes: intelligent instrument manufacturing; Industrial automatic control system device manufacturing; Research and development of mechanical equipment; Intelligent control system integration; Internet of things equipment sales; Geographic remote sensing information service, etc. Enterprise survey shows that the company is jointly owned by Hanwei Water Technology (Henan) Co., Ltd. and Li Yuhua, a subsidiary of Hanwei Technology.
Another South Korean lawmaker from Yin Xiyue's party said that he would vote to impeach Yin Xiyue.ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.Survey by Monetary Authority of Singapore: Economists have lowered Singapore's non-oil domestic export growth forecast from 3.0% to 1.0% in 2024.
ADB approved a loan of US$ 200 million for power infrastructure construction in Pakistan.China strongly condemns Canada's illegal sanctions against relevant Chinese personnel. On the 10th, a spokesman for the Chinese Embassy in Canada said that the Canadian Ministry of Foreign Affairs, under the pretext of so-called human rights, had planted and smeared China and announced that it had imposed illegal sanctions on relevant Chinese personnel, which seriously violated international law and the basic norms of international relations and seriously interfered in China's internal affairs. China firmly opposed this and strongly condemned it. (Xinhua News Agency)According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).